For the first time in its 28-year history, the Prix Galien, which is presented to the medicine which has made the most significant contribution to patient care, is to be awarded on an international basis.
The award is sponsored by the UK Department of Health, Janssen-Cilag, Glaxo Wellcome and Excerpta Medica. The winners of the first international price will be announced at an award ceremony in London on November 6.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze